Weekly Sepsis Research Analysis
This week’s sepsis literature emphasized pragmatic implementation to reduce infection harms, mechanistic discoveries that prioritize druggable targets, and diagnostic/prognostic advances that can be deployed at the bedside. High-quality randomized and population-level implementation trials demonstrated reductions in maternal and neonatal antibiotic exposure and maternal infection-related morbidity. Several translational studies (genetic/proteomic MR, endothelial barrier biology, epigenetic-metab
Summary
This week’s sepsis literature emphasized pragmatic implementation to reduce infection harms, mechanistic discoveries that prioritize druggable targets, and diagnostic/prognostic advances that can be deployed at the bedside. High-quality randomized and population-level implementation trials demonstrated reductions in maternal and neonatal antibiotic exposure and maternal infection-related morbidity. Several translational studies (genetic/proteomic MR, endothelial barrier biology, epigenetic-metabolic mechanisms) and robust cohort analyses inform candidate therapeutic targets and timing of organ support.
Selected Articles
1. A Multicomponent Intervention to Improve Maternal Infection Outcomes.
A cluster-randomized trial across 59 facilities in Malawi and Uganda (431,394 births) tested the APT-Sepsis program (WHO hand hygiene, evidence-based infection prevention/management, FAST-M bundle) and found a reduction in a composite of infection-related maternal death, near-miss, or severe infection from 1.9% to 1.4% (risk ratio 0.68; P<0.001). Effects were consistent and sustained across contexts.
Impact: Provides high-quality randomized evidence that a scalable implementation program reduces maternal infection-related harms in low-resource settings, directly supporting policy and large-scale adoption.
Clinical Implications: Health systems in similar settings should prioritize implementation of WHO-aligned hand hygiene, evidence-based infection prevention, and FAST-M bundle with monitoring of fidelity and outcomes; adaptation and scale-up with cost-effectiveness assessment are warranted.
Key Findings
- Cluster-RCT of 59 facilities reduced composite infection-related maternal outcomes from 1.9% to 1.4% (risk ratio 0.68; 95% CI 0.55–0.83; P<0.001).
- Intervention combined WHO hand hygiene, evidence-based infection prevention/management, and FAST-M (fluids, antibiotics, source control, transfer, monitoring).
- Effects were consistent across countries, facility sizes, and sustained over time.
2. Serial physical examination to reduce unnecessary antibiotic exposure in newborn infants: a population-based study.
A population-based multicenter intervention across six Norwegian NICUs (54,713 eligible liveborn infants) implemented serial physical examination (24–48 hours) for infants at risk of EOS, reducing antibiotic exposure from 1.8% to 0.9% (50% reduction) without increases in culture-positive EOS, NICU admissions, or safety events.
Impact: Demonstrates a pragmatic, low-cost, scalable strategy to halve neonatal empiric antibiotic exposure safely — directly applicable to antimicrobial stewardship and neonatal care protocols.
Clinical Implications: NICUs should consider structured SPE pathways for ≥34-week infants at EOS risk to reduce unnecessary empiric antibiotics while maintaining safety; protocols should include clear triggers for prompt antibiotic initiation on deterioration.
Key Findings
- Antibiotic exposure decreased by 50% (1.8% to 0.9%) after implementing serial physical examination.
- No increase in culture-positive EOS, NICU admissions, time-to-antibiotics for EOS, infection-related deaths, or re-admissions.
- SPE provided a safety net by monitoring 24–48 hours and permitting immediate treatment escalation if deterioration occurred.
3. Time to Full Enteral Feeds and Late-Onset Sepsis in Extremely Preterm Infants.
A secondary analysis of a prospective multicenter cohort (15,102 extremely preterm infants from 19 US centers) found that each 1-week delay in achieving full enteral feeds was associated with a 16% higher adjusted risk of late-onset sepsis (ARR 1.16). Delays also correlated with higher NEC and growth faltering; median time to full feeds decreased over the decade alongside reduced late-onset sepsis.
Impact: Large, contemporary multicenter data link a modifiable care process (speed of feeding advancement) to late-onset sepsis and NEC risk in extremely preterm infants, informing neonatal nutritional practice.
Clinical Implications: Adopt safe protocols to accelerate advancement to full enteral feeding (with monitoring for tolerance) in extremely preterm infants to potentially reduce late-onset sepsis, NEC, and growth faltering; test protocols prospectively.
Key Findings
- Each 1-week delay to full enteral feeds increased late-onset sepsis risk by 16% (ARR 1.16, 95% CI 1.14–1.18).
- Delays were associated with higher NEC risk and growth faltering in weight/length/head circumference.
- Over 2012–2021 median days to full feeds fell (18→14) while late-onset sepsis incidence decreased (21.1%→16.5%).